Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia

European Urology

Volumn 39, Issue 2, 2001, Pages 151-158

  Hammarsten, Jan ^a   Högstedt, Benkt ^b  

^a VARBERG HOSPITAL   (Sweden)

^b HALMSTAD HOSPITAL   (Sweden)

Author keywords

Benign prostatic hyperplasia; Dyslipidaemia; Hyperinsulinaemia; Hypertension; Metabolic syndrome; Non insulin dependent diabetes mellitus; Obesity

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; HUMAN; HYPERINSULINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; HUMANS; HYPERINSULINISM; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; RISK FACTORS;

EID: 0035108041     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052430     Document Type: Article

References (58)

1. Epidemiology and natural history of benign prostatic hyperplasia
2. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia
3. Benign prostatic hyperplasia: Antecedents and natural history
4. Benign prostatic hyperplasia: Medical and minimally invasive treatment options
5. The development of human benign prostatic hyperplasia with age
6. Benign prostatic hyperplasia
7. Altered blood androgens in elderly men with prostate hyperplasia
8. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy
9. Altered metabolism of androgens in elderly men with benign prostatic hyperplasia
10. Serum steroids in normal males and patients with prostatic diseases
11. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH)
12. Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma
13. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate
14. Comparative study of plasma steroid and steroid glucoronide levels in normal men and in men with benign prostatic hyperplasia
15. Components of the metabolic syndrome - Risk factors for the development of benign prostatic hyperplasia
16. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia
17. Pathology of benign prostatic hyperplasia
18. Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques
19. Determination of prostate volume by transrectal ultrasound
20. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
21. Banting lecture 1988: Role of insulin resistance in human disease
22. Role of muscle capillarization and morphology in the development of insulin resistance and metabolic syndrome
23. New aspects of insulin resistance in hypertension
24. Metabolic effects of weight loss in obese subjects. Changes in plasma substrate levels, insulin and growth hormone responses
25. Effects of weight loss in massive obesity on insulin and c-peptide dynamics: Sequential changes in insulin production, clearance, and sensitivity
26. Depletion and disruption of dietary fibre: Effects on satiety, plasma-glucose, and serum-insulin
27. Effects of four meals with different kinds of dietary fibre on glucose metabolism in healthy subjects and non-insulin-dependent diabetic patients
28. The effect of physical training on insulin production in obesity
29. Relationship between muscle morphology and metabolism in obese women: The effects of long-term physical training
30. Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women
31. Effect of physical training on insulin action in obesity
32. Life style changes improve insulin resistance in hyperinsulinaemic subjects: A one-year intervention study of hypertensives and normotensives in Dalby
33. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study
34. Serum insulin response to oral glucose load during a dietary intervention trail in healthy coronary high risk men: The Oslo study
35. Physical activity and benign prostatic hyperplasia
36. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia
37. Diet and benign prostatic hyperplasia: A study in Greece
38. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors
39. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension
40. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension
41. Effect of prozasin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension
42. Treatment with a beta-blocker with beta2-agonism improves glucose and lipid metabolism in essential hypertension
43. Effects of selective alpha1 and beta1 adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity
44. Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow
45. Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension
46. Age-related changes in muscle sympathetic nerve activity in essential hypertension
47. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings
48. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension
49. Relation of obesity and diet to sympathetic nervous system activity
50. Sympathetic activation in obese normotensive subjects
51. Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans
52. The sympathetic response to euglycaemic hyperinsulinemia: Evidence from microelectrode nerve recordings in healthy subjects
53. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man
54. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats
55. Diet, obesity and hypertension: An hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis
56. The sympathetic outflow in vasoconstrictor nerve fascicles to muscle is increased during euglycaemic hyperinsulinaemia
57. Alpha1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia
58. Natural history of prostatism: Relationship among symptoms, prostate volume and peak urinary flow rate